CrushSCI.com
Journal Selection & Manuscript Polishing Services
CTS-Clinical and Translational Science journal cover Medicine
Back to journal directory

Review Cycle Records

CTS-Clinical and Translational Science

Wiley SCIE OA
2026 Emerging Zone 32025 CAS Zone 32025 JCR Q2
132.6Average days
126Median days
31Fastest days
255Longest days
3582025 publications

Paper Review Records

All Paper Review Records

20 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

93 days

Prognostic Value of Systemic Inflammatory Markers in Predicting Peritoneal Metastasis in Gastric and Gastroesophageal Junction Cancer

AuthorsMahesh Wadhwa; Dipali Raju; Harish Premkumar; Nawaz Usman; Preethi S. Shetty; Naveena A. N. Kumar

Affiliations1. Department of Surgical Oncology Kasturba Medical College, Manipal Academy of Higher Education Manipal India; 2. Department of Applied Statistics and Data Science, Prasanna School of Public Health Manipal Academy of Higher Education Manipal India

Source PDF DOI Publisher page
115 days

Quantitative and Clinical Pharmacology Perspectives on Next‐Generation Malaria Prevention Using Vaccines and Long‐Acting Monoclonal Antibodies

AuthorsSabiha R. Mim; Leonardo C. Xavier; Francine J. Azeredo; Sihem Ait‐Oudhia

Affiliations1. Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy University of Florida Orlando Florida USA; 2. Quantitative Pharmacology and Pharmacometrics (QP2), Merck & Co., Inc Rahway New Jersey USA

Source PDF DOI Publisher page
207 days

Pharmacokinetic Drug–Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential

AuthorsAmita Datta‐Mannan; Elaine Shanks; Eunice Yuen; Vivian Rodriguez Cruz; Xuejing Aimee Wang; Stephen David Hall

Affiliations1. Eli Lilly and Company Indianapolis Indiana USA; 2. Eli Lilly and Company Bracknell UK

Source PDF DOI Publisher page
136 days

Association of the NOS1AP rs10494366 Genetic Variant With Drug‐Induced QT Prolongation

AuthorsChristina A. Pippis; Ana I. Lopez‐Medina; Choudhary Anwar A. Chahal; Jasmine A. Luzum

Affiliations1. Department of Clinical Pharmacy University of Michigan College of Pharmacy Ann Arbor Michigan USA; 2. Center for Inherited Cardiovascular Diseases WellSpan Health Lancaster Pennsylvania USA; 3. Department of Cardiovascular Medicine Mayo Clinic Rochester Minnesota USA; 4. Department of Cardiology Barts Heart Centre London UK

Source PDF DOI Publisher page
86 days

A Serverless Pharmacogenomic Risk Dashboard: Translating Ensemble Models and Model‐Based Scenario Rules to Clinical Decision Support

AuthorsR. Jerome Dixon; Elvin T. Price

Affiliations1. Department of Pharmacotherapy and Outcomes Science, School of Pharmacy Virginia Commonwealth University Richmond Virginia USA; 2. Ph.D. Program in Integrative Life Sciences, School of Life Sciences and Sustainability Virginia Commonwealth University Richmond Virginia USA; 3. ConvergenceLabs@VCU—Health Outcomes Virginia Commonwealth University Richmond Virginia USA

Source PDF DOI Publisher page
208 days

Brexanolone, a First‐In‐Class Neurosteroid Medication: Mechanism of Action, Clinical, and Translational Science

AuthorsLaura Gayanova; Katrina Sian; Jason Wells; Amber Fedin; YanFei Qi

Affiliations1. Duquesne University Nasuti College of Osteopathic Medicine Pittsburgh Pennsylvania USA

Source PDF DOI Publisher page
77 days

Empowering Clinical Development With Disease Progression Modeling: Recommendations From the Clinical Trials Transformation Initiative

AuthorsLindsay S. Kehoe; Shu Chin Ma; Jiang Liu; Qi Liu; Herbert Pang; Bruce Burnett; Reem Yunis; Karthik Venkatakrishnan

Affiliations1. The Clinical Trials Transformation Initiative Duke Clinical Research Institute Durham North Carolina USA; 2. Model‐Informed Drug Development and Quantitative Medicine Critical Path Institute Tucson Arizona USA; 3. Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research U.S. Food and Drug Administration Silver Spring Maryland USA; 4. PD Data Science & Analytics Genentech South San Francisco California USA; 5. Division of Allergy, Immunology and Transplantation, National Institute of Allergy and Infectious Diseases National Institutes of Health Bethesda Maryland USA; 6. RAYS Partners Consulting Menlo Park California USA; 7. EMD Serono Research and Development Institute, Inc. Billerica Massachusetts USA

Source PDF DOI Publisher page
131 days

Deep‐Learning: An Emerging Tool to Support Model‐Informed Drug Development

AuthorsRoberto Gomeni; Françoise Bressolle‐Gomeni

Affiliations1. R&D Department PharmacoMetrica La Fouillade France

Source PDF DOI Publisher page
178 days

Device and Data Access Considerations for Digital Health Studies Using Consumer‐Grade Wearables: An Experience‐Based Tutorial

AuthorsMike Zhu; Joshua D. Spencer; Sherry Chesak; Magdalena Romanowicz; Mohit Chauhan; Liselotte N. Dyrbye; Paul E. Croarkin; William V. Bobo; Arjun P. Athreya

Affiliations1. Department of Molecular Pharmacology and Experimental Therapeutics Mayo Clinic Rochester Minnesota USA; 2. Digital Technology Organization, Information Technology Mayo Clinic Rochester Minnesota USA; 3. Department of Nursing Mayo Clinic Rochester Minnesota USA; 4. School of Nursing University of Minnesota Minneapolis Minnesota USA; 5. Department of Psychiatry and Psychology Mayo Clinic Rochester Minnesota USA; 6. Department of Psychiatry and Psychology Mayo Clinic Jacksonville Florida USA; 7. Department of Medicine University of Colorado School of Medicine Denver Colorado USA; 8. Mayo Clinic Children's Mayo Clinic Rochester Minnesota USA; 9. Department of Behavioral Sciences and Social Medicine Florida State University Tallahassee Florida USA; 10. Center for Medicine and Public Health Policy and Practice Florida State University Tallahassee Florida USA

Source PDF DOI Publisher page
98 days

Temporal Drivers of Opioid‐Related ED Visits: An Ensemble Machine Learning Study With Consensus‐Based Feature Attribution

AuthorsR. Jerome Dixon; Elvin T. Price

Affiliations1. Department of Pharmacotherapy and Outcomes Science, School of Pharmacy Virginia Commonwealth University Richmond Virginia USA; 2. Ph.D. Program in Integrative Life Sciences, School of Life Sciences and Sustainability Virginia Commonwealth University Richmond Virginia USA; 3. ConvergenceLabs@VCU—Health Outcomes Virginia Commonwealth University Richmond Virginia USA

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.